<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04180631</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-1808-155-967</org_study_id>
    <nct_id>NCT04180631</nct_id>
  </id_info>
  <brief_title>Quantitative US for Hepatic Steatosis</brief_title>
  <official_title>Diagnostic Value of Quantitative Ultrasound Imaging Parameters for Hepatic Steatosis in Patients With Non-alcoholic Fatty Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Samsung Medison</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the diagnostic performance of quantitative
      ultrasound imaging parameter for the assessment of hepatic steatosis in patients with
      non-alcoholic fatty liver disease using magnetic resonance imaging proton density fat
      fraction (MRI-PDFF) and MR spectroscopy as the reference standard.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 5, 2019</start_date>
  <completion_date type="Actual">January 19, 2020</completion_date>
  <primary_completion_date type="Actual">January 19, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between quantitative US imaging parameter (QUS) and MR fat fraction</measure>
    <time_frame>3 months</time_frame>
    <description>reference standard: MR spectroscopy or MRI-proton density fat fraction value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance of QUS to detect mild fatty liver and moderate fatty liver</measure>
    <time_frame>3 months</time_frame>
    <description>reference standard: MR fat fraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between S-shearwave elastography and MR elastography</measure>
    <time_frame>3 months</time_frame>
    <description>Reference standard: liver stiffness at MR elastography, using Pearson's correlation analysis or Spearman rank correlation analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-observer agreement of quantitative ultrasound imaging parameter</measure>
    <time_frame>same 1 day</time_frame>
    <description>intraclass correlation coefficient (ICC)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">124</enrollment>
  <condition>Hepatic Steatosis</condition>
  <arm_group>
    <arm_group_label>Quantitative ultrasound imaging parameter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Quantitative ultrasound imaging parameter (QUS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Quantitative ultrasound imaging parameter (QUS)</intervention_name>
    <description>Quantitative ultrasound imaging parameters (QUS) are analyzed to evaluate hepatic steatosis</description>
    <arm_group_label>Quantitative ultrasound imaging parameter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with clinically suspected non-alcoholic fatty liver disease (NAFLD) or
             non-alcoholic steatohepatitis (NASH), or living-donor candidates for liver
             transplantation, or volunteers

          -  Signed informed consent

        Exclusion Criteria:

          -  chronic liver disease patients (serum HBsAg positive or anti-hepatitis C virus (HCV),
             histologic confirmation)

          -  chronic alcoholics

          -  serum alanine transaminase (ALT)&gt;5 times the upper limit of normal within 3 months

          -  previous liver surgery

          -  acute hepatitis or bile duct obstruction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeon Min Lee</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2019</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jeong Min Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fatty Liver</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

